 |
 |

Cholesterol and Coronary Heart DiseaseThe Importance of Patient-Specific Attributable Risk
David J. Malenka, MD;
John A. Baron, MD
Arch Intern Med. 1988;148(10):2247-2252.
Abstract
 |  |
The value of treating hypercholesterolemia remains controversial despite extensive investigation, in part because of the research orientation of much of the relevant literature. Most published studies report relative measures of risks such as the risk ratio. However, clinicians are concerned with the magnitude of risk, or attributable risk, the difference in risk in those with highest and lowest serum cholesterol levels. Since maximum risk modification is rarely achieved, the attributable risk often overstates the potential benefit of risk factor reduction. A variant of the attributable risk, the practical attributable risk, gives a more realistic estimate of potential benefit. Since clinicians treat individuals and not populations, these measures of risk are most useful if reported for subgroups of patients (eg, men and women, as well as those of varying age). To illustrate these concepts, we review the literature on hypercholesterolemia, report the risk ratio, attributable risk, and practical attributable risk for important patient populations, and discuss the implications for clinical practice.
(Arch Intern Med 1988;148:2247-2252)
Author Affiliations
From the Departments of Medicine (Drs Malenka and Baron), Dartmouth-Hitchock Medical Center, Hanover, NH, and White River Junction (Vt) Veterans Administration Medical Center (Dr Malenka).
Footnotes
Accepted for publication April 28, 1988.
Reprint requests to Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH 03756 (Dr Malenka).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Nutrition and Health Promotion in Older Adults
Chernoff
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001;56:47-53.
ABSTRACT
| FULL TEXT
Effects of Hormone Replacement Therapy on Serum Lipids in Elderly Women: A Randomized, Placebo-Controlled Trial
Binder et al.
ANN INTERN MED 2001;134:754-760.
ABSTRACT
| FULL TEXT
Cholesterol Lowering in the Elderly Population
Grundy et al.
Arch Intern Med 1999;159:1670-1678.
ABSTRACT
| FULL TEXT
HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons
Corti et al.
JAMA 1995;274:539-544.
ABSTRACT
Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans
Garber et al.
Arch Intern Med 1991;151:1089-1095.
ABSTRACT
Cholesterol and Coronary Heart Disease: Future Directions
Grundy
JAMA 1990;264:3053-3059.
ABSTRACT
High Blood Cholesterol in Elderly Men and the Excess Risk for Coronary Heart Disease
Rubin et al.
ANN INTERN MED 1990;113:916-920.
ABSTRACT
Apolipoproteins A-I and B as Predictors of Angiographically Defined Coronary Artery Disease
Reinhart et al.
Arch Intern Med 1990;150:1629-1633.
ABSTRACT
Reducing Cholesterol Levels in Elderly Persons
Brotons
JAMA 1990;263:2889-2890.
ABSTRACT
Hypercholesterolemia in Elderly Persons: Resolving the Treatment Dilemma
Denke and Grundy
ANN INTERN MED 1990;112:780-792.
ABSTRACT
Cholesterol and Coronary Heart Disease: The Attributable Risk Reduction of Diet and Drugs
Malenka and Baron
Arch Intern Med 1989;149:1981-1985.
ABSTRACT
Internal Medicine
Fletcher
JAMA 1989;261:2853-2855.
ABSTRACT
|